Literature DB >> 15246050

Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors.

Alberto Mantovani1, Paola Allavena, Silvano Sozzani, Annunciata Vecchi, Massimo Locati, Antonio Sica.   

Abstract

Leukocytes, and macrophages in particular, are an important component of the stroma of neoplastic tissues. Tumor-associated macrophages (TAM) have the properties of a polarized M2 population and are a key component of inflammatory circuits which promote tumor growth and progression. Chemokines play a key role in the recruitment and positioning of TAM and dendritic cells in tumors and contribute to shaping their functional properties. Chemokine-recruited and positioned tumor infiltrating leukocytes are a key component of inflammatory circuits which promote tumor progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246050     DOI: 10.1016/j.semcancer.2003.10.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  62 in total

Review 1.  Macrophages as mediators of tumor immunosurveillance.

Authors:  Siddhartha Jaiswal; Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Trends Immunol       Date:  2010-05-07       Impact factor: 16.687

2.  Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.

Authors:  Russell K Pachynski; Alexander Scholz; Justin Monnier; Eugene C Butcher; Brian A Zabel
Journal:  J Vis Exp       Date:  2015-04-13       Impact factor: 1.355

3.  The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regions.

Authors:  Kenichi Kimura; Masumi Nagano; Georgina Salazar; Toshiharu Yamashita; Ikki Tsuboi; Hajime Mishima; Shonosuke Matsushita; Fujio Sato; Kenji Yamagata; Osamu Ohneda
Journal:  Stem Cells Dev       Date:  2013-12-14       Impact factor: 3.272

4.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

5.  Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.

Authors:  Sophie Kirshberg; Uzi Izhar; Gail Amir; Jonathan Demma; Fiona Vernea; Katia Beider; Zippora Shlomai; Hanna Wald; Gideon Zamir; Oz M Shapira; Amnon Peled; Ori Wald
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

6.  CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization.

Authors:  Hernan Roca; Zachary S Varsos; Sudha Sud; Matthew J Craig; Chi Ying; Kenneth J Pienta
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

7.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

8.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

9.  Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions.

Authors:  Lido Calorini; Francesca Bianchini
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

10.  Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.

Authors:  Daniela Bosisio; Marisa Vulcano; Annalisa Del Prete; Marina Sironi; Valentina Salvi; Laura Salogni; Elena Riboldi; Flavio Leoni; Charles A Dinarello; Giampiero Girolomoni; Silvano Sozzani
Journal:  J Leukoc Biol       Date:  2008-09-09       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.